Sign in
AGMB Stock Price, Chart, Stats & News
AgomAb Therapeutics N.V. American Depositary Shares
Save
877.60M
Market cap
–
Current P/E
–
Forward P/E
AGMB chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.01% |
ROA | – |
ROE | – |
D/E | – |
Interest coverage ratio | -716.73x |
AGMB valuation
P/E | – |
P/S | – |
P/B | – |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | -0.08x |
EV multiple | -0.01x |
About
AgomAb Therapeutics N. V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, particularly chronic fibrotic conditions where significant unmet medical needs persist.
Similar securities
Based on sector and market capitalization
Report issue